Elon Musk (Patrick Pleul/Pool via AP, Arquivo)
November 14, 2022 11:20 AM ESTUpdated 12:10 PM
Pharma
Marketing

Eli Lil­ly pulls mil­lions in Twit­ter ad­ver­tis­ing af­ter fake ac­count de­ba­cle — re­port

Beth Snyder Bulik

Senior Editor

Eli Lil­ly is pulling its mil­lions in ad spend­ing on Twit­ter af­ter last week’s fake posts de­ba­cle, ac­cord­ing to a news re­port.

When an im­poster …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times